MMI symposium to focus on Lou Gehrig’s disease

The UNMC Munroe-Meyer Institute will host a symposium on amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig’s disease, on Sept. 28 in the Sorrell Center.

The goal is to provide valuable information from an interdisciplinary perspective to families, educators, health care professionals and others who interact with adults with ALS so that quality of treatment for persons with ALS improves.

Leading experts in medicine, genetics and behavioral health will share the latest research, insights and multidisciplinary treatments for adults with ALS. The program will cover a range of important and, in some cases, controversial topics in health care today, including:

  • The nature and etiology of ALS.
  • Biomedical, behavioral and educational interventions.
  • Specific considerations for ALS.
  • Resources for individuals with ALS and their families.

Terry Heiman-Patterson, M.D., professor and vice chairman of the department of neurology as well as the chief of neuromuscular diseases at Drexel University College of Medicine, will deliver the keynote speech — “Advances in the Neurobiology of ALS.”

Dr. Heiman-Patterson directs the MDA ALS Center of Hope at Drexel and also the MDA Clinic at Good Shepherd Rehabilitation Hospital in Allentown, Pa.

Registration is $75 for professionals and $25 for students, family members and others. The deadline to register is Sept. 23 at 5 p.m.

Attendees will be provided with a certificate of attendance for six contact hours of continuing education credit.